In Situ Gel of Triamcinolone Acetonide-Loaded Solid Lipid Nanoparticles for Improved Topical Ocular Delivery: Tear Kinetics and Ocular Disposition Studies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Situ Gel of Triamcinolone Acetonide-Loaded Solid Lipid Nanoparticles for Improved Topical Ocular Delivery: Tear Kinetics and Ocular Disposition Studies
Authors
Keywords
-
Journal
Nanomaterials
Volume 9, Issue 1, Pages 33
Publisher
MDPI AG
Online
2018-12-28
DOI
10.3390/nano9010033
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Curcumin-loaded Nanostructured Lipid Carriers for ocular drug delivery: Design optimization and characterization
- (2018) Prit Lakhani et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery
- (2018) Juan C. Altamirano-Vallejo et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Ion-sensitive in situ hydrogels of natamycin bilosomes for enhanced and prolonged ocular pharmacotherapy: in vitro permeability, cytotoxicity and in vivo evaluation
- (2018) Karthik Yadav Janga et al. Artificial Cells Nanomedicine and Biotechnology
- Research progress of in-situ gelling ophthalmic drug delivery system
- (2018) Yumei Wu et al. Asian Journal of Pharmaceutical Sciences
- Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye – Part I – Barriers and determining factors in ocular delivery
- (2017) E. Sánchez-López et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation
- (2017) Narendar Dudhipala et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye – Part II - Ocular drug-loaded lipid nanoparticles
- (2017) E. Sánchez-López et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol
- (2017) Sai Prachetan Balguri et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Solid lipid nanoparticle: an efficient carrier for improved ocular permeation of voriconazole
- (2016) Rakesh Kumar et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues
- (2016) Sai Prachetan Balguri et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The Effect of Silica Nanoparticles on Human Corneal Epithelial Cells
- (2016) Joo-Hee Park et al. Scientific Reports
- Cyclodextrin–polysaccharide-based, in situ-gelled system for ocular antifungal delivery
- (2014) Anxo Fernández-Ferreiro et al. Beilstein Journal of Organic Chemistry
- Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation
- (2014) Narendar Dudhipala et al. DRUG DELIVERY
- Influence of co-surfactants on crystallization and stability of solid lipid nanoparticles
- (2014) Hanna Salminen et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery
- (2014) Biswaranjan Mohanty et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Intravitreal Steroids for the Treatment of Retinal Diseases
- (2014) Valentina Sarao et al. TheScientificWorldJOURNAL
- Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery
- (2013) Jifu Hao et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: Design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits
- (2013) Saadia Ahmed Tayel et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Indomethacin-Loaded Solid Lipid Nanoparticles for Ocular Delivery: Development, Characterization, and In Vitro Evaluation
- (2013) Ketan Hippalgaonkar et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Solid lipid nanoparticles
- (2012) Wolfgang Mehnert et al. ADVANCED DRUG DELIVERY REVIEWS
- In situgel systems as ‘smart’ carriers for sustained ocular drug delivery
- (2012) Ashish Kumar Agrawal et al. Expert Opinion on Drug Delivery
- Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye
- (2011) Joana Araújo et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Ocular Drug Delivery
- (2010) Ripal Gaudana et al. AAPS Journal
- Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications
- (2010) J. Araújo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Ion- and pH-activated novelin-situgel system for sustained ocular drug delivery
- (2010) Himanshu Gupta et al. JOURNAL OF DRUG TARGETING
- Sustained Release and Permeation of Timolol from Surface-Modified Solid Lipid Nanoparticles through Bioengineered Human Cornea
- (2009) A. A. Attama et al. CURRENT EYE RESEARCH
- Vitreal Kinetics of Quinidine in Rabbits in the Presence of Topically Coadministered P-Glycoprotein Substrates/Modulators
- (2009) S. Majumdar et al. DRUG METABOLISM AND DISPOSITION
- Multilamellar liposomes of triamcinolone acetonide: preparation, stability, and characterization
- (2009) B Clares et al. JOURNAL OF LIPOSOME RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started